FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anna-Sophia Kiang

Research Profile

Disorders

Retinitis Pigmentosa

Living Beings

Chemicals & Drugs

Phenomena

RNA Interference

Procedures

Genetic Therapy

Physiology

Concepts & Ideas

Co-author Network

Publications

TOP 3
Sarah L Doyle; Gwyneth Jane Farrar; Joe G Hollyfield; Marian Humphries; Paul F Kenna; Anna-Sophia Kiang; E C Lavelle; Andres Mori; Luke A J O'Neill; Ema Ozaki; Robert G Salomon; Matthew Campbell; Peter Humphries
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components.
Matthew Campbell; Colin P Doherty; OL Gobbo; Gerald A Grant; Finnian Hanrahan; Marian Humphries; James Keaney; Michael E Kelly; Christian M Kerskens; Anna-Sophia Kiang; Anh T H Nguyen; Ema Ozaki; Eugene Wallace; Christoph W Blau; Stephen D Cahalan; John J Callanan; Peter Humphries
Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury.
Matthew Campbell; Marian Humphries; Anna-Sophia Kiang; Anh T H Nguyen; OL Gobbo; Lawrence C S Tam; Mayu Suzuki; Finnian Hanrahan; Ema Ozaki; G Jane Farrar; Paul F Kenna; Peter Humphries
Systemic low-molecular weight drug delivery to pre-selected neuronal regions.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anna-Sophia Kiang (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Sarah L Doyle; Gwyneth Jane Farrar; Joe G Hollyfield; Marian Humphries; Paul F Kenna; Anna-Sophia Kiang; E C Lavelle; Andres Mori; Luke A J O'Neill; Ema Ozaki; Robert G Salomon; Matthew Campbell; Peter Humphries
NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components.
Nature medicine 2012;18(5):791-8.
2012: Matthew Campbell; Colin P Doherty; OL Gobbo; Gerald A Grant; Finnian Hanrahan; Marian Humphries; James Keaney; Michael E Kelly; Christian M Kerskens; Anna-Sophia Kiang; Anh T H Nguyen; Ema Ozaki; Eugene Wallace; Christoph W Blau; Stephen D Cahalan; John J Callanan; Peter Humphries
Targeted suppression of claudin-5 decreases cerebral oedema and improves cognitive outcome following traumatic brain injury.
Nature communications 2012;3():849.
2011: Matthew Campbell; Marian Humphries; Anna-Sophia Kiang; Anh T H Nguyen; OL Gobbo; Lawrence C S Tam; Mayu Suzuki; Finnian Hanrahan; Ema Ozaki; G Jane Farrar; Paul F Kenna; Peter Humphries
Systemic low-molecular weight drug delivery to pre-selected neuronal regions.
EMBO molecular medicine 2011;3(4):235-45.
2010: Lawrence C S Tam; Anna-Sophia Kiang; Naomi Chadderton; Paul F Kenna; Matthew Campbell; Marian Humphries; G Jane Farrar; Peter Humphries
Protection of photoreceptors in a mouse model of RP10.
Advances in experimental medicine and biology 2010;664():559-65.
2010: Matthew Campbell; Anh Thi Hong Nguyen; Anna-Sophia Kiang; Lawrence Tam; Paul F Kenna; Sorcha Ni Dhubhghaill; Marian Humphries; G Jane Farrar; Peter Humphries
Reversible and size-selective opening of the inner Blood-Retina barrier: a novel therapeutic strategy.
Advances in experimental medicine and biology 2010;664():301-8.
2009: Matthew Campbell; Anh T H Nguyen; Anna-Sophia Kiang; Lawrence C S Tam; OL Gobbo; Christian Kerskens; Sorcha Ni Dhubhghaill; Marian Humphries; G Jane Farrar; Paul F Kenna; Peter Humphries
An experimental platform for systemic drug delivery to the retina.
Proceedings of the National Academy of Sciences of the United States of America 2009;106(42):17817-22.
2008: Matthew Campbell; Anna-Sophia Kiang; Paul F Kenna; Christian Kerskens; Christoph Blau; Laurence O'Dwyer; Amanda Tivnan; Julie Anne Kelly; Brenda Brankin; G Jane Farrar; Peter Humphries
RNAi-mediated reversible opening of the blood-brain barrier.
The journal of gene medicine 2008;10(8):930-47.
2008: Lawrence C S Tam; Anna-Sophia Kiang; Avril Kennan; Paul F Kenna; Naomi Chadderton; Marius Ader; Arpad Palfi; Aileen Aherne; Carmen Ayuso; Matthew Campbell; Alison Reynolds; Alex McKee; Marian Humphries; G Jane Farrar; Peter Humphries
Therapeutic benefit derived from RNAi-mediated ablation of IMPDH1 transcripts in a murine model of autosomal dominant retinitis pigmentosa (RP10).
Human molecular genetics 2008;17(14):2084-100.
2007: Mary O'REILLY; Arpad Palfi; Naomi Chadderton; Sophia Millington-Ward; Marius Ader; Thérèse Cronin; Thérèse Tuohy; Alberto Auricchio; Markus Hildinger; Amanda Tivnan; Niamh McNally; Marian Humphries; Anna-Sophia Kiang; Peter Humphries; Paul F Kenna; G Jane Farrar
RNA interference-mediated suppression and replacement of human rhodopsin in vivo.
American journal of human genetics 2007;81(1):127-35.
2006: Arpad Palfi; Marius Ader; Anna-Sophia Kiang; Sophia Millington-Ward; Gerry Clark; Mary O'REILLY; Helena P McMahon; Paul F Kenna; Peter Humphries; G Jane Farrar
RNAi-based suppression and replacement of rds-peripherin in retinal organotypic culture.
Human mutation 2006;27(3):260-8.
2005: Anna-Sophia Kiang; Arpad Palfi; Marius Ader; Paul F Kenna; Sophia Millington-Ward; Gerry Clark; Avril Kennan; Mary O'REILLY; Lawrence C T Tam; Aileen Aherne; Niamh McNally; Peter Humphries; G Jane Farrar
Toward a gene therapy for dominant disease: validation of an RNA interference-based mutation-independent approach.
Molecular therapy : the journal of the American Society of Gene Therapy 2005;12(3):555-61.
2004: Sophia Millington-Ward; Helena P McMahon; Danny Allen; Gearóid Tuohy; Anna-Sophia Kiang; Arpad Palfi; Paul F Kenna; Peter Humphries; G Jane Farrar
RNAi of COL1A1 in mesenchymal progenitor cells.
European journal of human genetics : EJHG 2004;12(10):864-6.
2004: Aileen Aherne; Avril Kennan; Paul F Kenna; Niamh McNally; David Lloyd; Ian L Alberts; Anna-Sophia Kiang; Marian Humphries; Carmen Ayuso; Paul C Engel; Jing-Jin Gu; Beverly S Mitchell; G Jane Farrar; Peter Humphries
On the molecular pathology of neurodegeneration in IMPDH1-based retinitis pigmentosa.
Human molecular genetics 2004;13(6):641-50.
2000: Brian O'Neill; Sophia Millington-Ward; Mary O'REILLY; Gearóid Tuohy; Anna-Sophia Kiang; Paul F Kenna; Peter Humphries; G Jane Farrar
Ribozyme-based therapeutic approaches for autosomal dominant retinitis pigmentosa.
Investigative ophthalmology & visual science 2000;41(10):2863-9.
1999: Sophia Millington-Ward; Brian O'Neill; Anna-Sophia Kiang; Peter Humphries; Paul F Kenna; G Jane Farrar
A mutation-independent therapeutic strategem for osteogenesis imperfecta.
Antisense & nucleic acid drug development 1999;9(6):537-42.
1999: FC Mansergh; Sophia Millington-Ward; Avril Kennan; Anna-Sophia Kiang; Marian Humphries; G Jane Farrar; Peter Humphries; Paul F Kenna
Retinitis pigmentosa and progressive sensorineural hearing loss caused by a C12258A mutation in the mitochondrial MTTS2 gene.
American journal of human genetics 1999;64(4):971-85.
1999: N al-Jandal; G Jane Farrar; Anna-Sophia Kiang; Marian Humphries; N Bannon; J B Findlay; Peter Humphries; Paul F Kenna
A novel mutation within the rhodopsin gene (Thr-94-Ile) causing autosomal dominant congenital stationary night blindness.
Human mutation 1999;13(1):75-81.
1998: FC Mansergh; Paul F Kenna; Carmen Ayuso; Anna-Sophia Kiang; Peter Humphries; G Jane Farrar
Novel mutations in the TIGR gene in early and late onset open angle glaucoma.
Human mutation 1998;11(3):244-51.
1997: Sophia Millington-Ward; Brian O'Neill; Gearóid Tuohy; N Al-Jandal; Anna-Sophia Kiang; Paul F Kenna; Arpad Palfi; P Hayden; FC Mansergh; Avril Kennan; Peter Humphries; G Jane Farrar
Strategems in vitro for gene therapies directed to dominant mutations.
Human molecular genetics 1997;6(9):1415-26.
1996: Marian Humphries; FC Mansergh; Anna-Sophia Kiang; S A Jordan; D M Sheils; M J Martin; G Jane Farrar; Paul F Kenna; M M Young; Peter Humphries
Three keratin gene mutations account for the majority of dominant simplex epidermolysis bullosa cases within the population of Ireland.
Human mutation 1996;8(1):57-63.